Wilson DR. Acquired platelet defects. In: Nathan DG, Orkin SH, Ginsburg D, Look TA, eds. Nathan and Oski's Hematology of Infancy and Childhood, ed. 6. Philadelphia: WB Saunders; 2003:1500-1609.
High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura
Law C, Marcaccio M, Tam P, et al. High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. N Engl J Med. 1997; 336:1494-1498.
Current controversies in the management of immune thrombocytopenic purpura during childhood
Medeiros D, Buchanan GR. Current controversies in the management of immune thrombocytopenic purpura during childhood. Pediatr Hematol. 1996;43:757-772.
Low dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: Results of a prospective, randomized single-center trial
Benesch M, Kerbl R, Lackner H, et al. Low dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial. J Pediatr Hematol Oncol. 2003; 25:797-800.
Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology
George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3.
A prospective comparative study of 2,450 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group
Kuhne T, Buchanan GR, Zimmermann S, et al. A prospective comparative study of 2,450 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group. J Pediatr. 2003; 143: 605-608.
Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: A prospective Nordic study of an unselected cohort
Rothoj S, Hedlund-Treutiger I, Rajantie J, et al. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: a prospective Nordic study of an unselected cohort. J Pediatr. 2003;143:302-307.
Clinical features and treatment outcomes of 79 infants with immune thrombocytopenic purpura
Sandoval C, Visintainer P, Ozkaynak F, et al. Clinical features and treatment outcomes of 79 infants with immune thrombocytopenic purpura. Pediatr Blood Cancer. 2004;42:109-112.
Isolated thrombocytopenia in children with acute lymphoblastic leukemia: A rare event in a Pediatric Oncology Group study
Dubansky AS, Boyett JM, Falletta J, et al. Isolated thrombocytopenia in children with acute lymphoblastic leukemia: a rare event in a Pediatric Oncology Group study. Pediatrics. 1989;84:1068-1071.
The child with immune thrombocytopenic purpura: Is pharmacotherapy or watchful waiting the best initial management?
Bolton-Maggs P, Tarantino MD, Buchanan GR, et al. The child with immune thrombocytopenic purpura: is pharmacotherapy or watchful waiting the best initial management? J Pediatr Hematol Oncol. 2004;26:146-151.